0001772016-25-000127
SEC filingNet sales grew 6% but operating profit fell 60% due to $68M legal provision; nine-month net income down 10%.
For the three months ended June 30, 2025, net sales increased 6% to $547.5M from $515.4M in the prior year period. Sales growth was driven by Premier Protein (+$26.3M, +6%) and Dymatize (+$3.6M, +5%). Premier Protein benefited from 3% higher volumes due to distribution gains and promotional activity, along with targeted price increases. Dymatize saw 5% volume growth from international markets and new products. Operating profit decreased 60% to $44.8M, primarily due to a $68.1M provision for legal matters and $18.6M higher net product costs (raw materials and manufacturing inflation, partially offset by lower freight). Net earnings fell 72% to $21.0M, influenced by the legal provision and a lower effective tax rate of 20.5% (vs. 24.2% last year) from discrete tax benefits.
For the nine months, net sales rose 16% to $1,668.4M, with Premier Protein up 18% ($214.6M) on 13% volume growth and Dymatize up 7% ($12.5M) on 12% volume growth. Operating profit decreased 7% to $255.2M, impacted by a $69.0M legal provision, $33.9M higher product costs, $22.8M increased advertising, and $9.5M higher warehousing costs, partially offset by the sales growth and $17.4M of accelerated amortization in the prior year. Net earnings declined 10% to $156.6M.
BellRing operates as a single reportable segment within the convenient nutrition category. The primary brands are Premier Protein and Dymatize. In Q3, Premier Protein sales grew 6% with volume driving most of the gain; average net selling prices increased due to targeted price increases but were partially offset by higher promotional activity. Dymatize sales grew 5% entirely from volume, with international markets and new products leading. The mix shift toward Premier Protein continued, as it represents the bulk of revenue. Operating margin contracted sharply due to the legal provision, but underlying product cost inflation was a headwind across both brands.
Management expects positive cash flows from operations and believes liquidity is sufficient for working capital, debt service, and share repurchases. Capital expenditures are modest (less than 1% of sales historically) with no significant planned outlays. The company faces ongoing inflationary pressures on raw materials, packaging, and manufacturing, and notes potential risks from tariffs. No specific numerical guidance was provided. The legal provision remains a one-time item, but its magnitude underscores litigation risk. The effective tax rate may be affected by the recently enacted H.R.1 Tax Act, though the impact is still under evaluation.
As of June 30, 2025, BellRing held $43.7M in cash and equivalents plus $11.2M restricted cash. Total assets were $993.7M, driven by inventory of $415.6M (up from $286.1M at September 30, 2024) and net intangible assets of $129.2M. The company operates with negative stockholders' equity of -$309.9M, primarily due to $566.6M in treasury stock. Long-term debt totaled $1,009.0M, consisting of $840.0M in 7.00% senior notes due 2030 and $175.0M drawn on the revolving credit facility, with available capacity of $75.0M.
The notes detail significant legal contingencies, notably the Joint Juice litigation. A class-wide settlement in principle was reached in June 2025, with $90.0M accrued in other current liabilities as of June 30, 2025. Additionally, the Protein Products Class Lawsuit was settled for an immaterial amount. No other material purchase commitments or contractual obligations were disclosed.
During the nine months ended June 30, 2025, BellRing repurchased 3.8M shares for $267.6M at an average price of $69.67. No dividends were paid. The company increased net debt by $175M through $360M in borrowings and $185M in repayments under its revolving credit facility. Capital expenditures were minimal at $3.7M.
BellRing operates as a single reportable segment, with revenue derived primarily from two brands: Premier Protein and Dymatize. Product-level revenue (Note 3) shows Shakes contributed $1,365.3M (81.8% of total) and Powders $261.6M (15.7%) for the nine months ended June 30, 2025. Other products accounted for the remainder. No geographic breakdown was provided in the notes.
Operating cash flow (CFO) of $91.5M was significantly lower than net earnings of $156.6M, primarily due to large working capital outflows. Inventories increased $128.3M, receivables rose $21.8M, and prepaid expenses increased $9.8M, partially offset by a $83.7M increase in payables. These working capital investments consumed cash, reducing CFO relative to earnings. Depreciation and amortization of $13.8M and non-cash stock compensation of $16.9M added back, but deferred tax benefits of $21.0M also reduced CFO.
Capital expenditures remained minimal at $3.7M (0.2% of revenue implied), indicating low capital intensity. Free cash flow (not explicitly stated) would be approximately $87.8M (CFO minus capex), but this was insufficient to cover massive share repurchases of $267.9M. The company financed buybacks and debt repayments through a $360.0M debt issuance, netting $175.0M in additional long-term debt. Net financing cash flow was negative $104.4M after repurchases and tax withholding payments.
Overall, cash generation from operations weakened due to inventory build, while shareholder returns were aggressive and debt-funded. The cash balance declined by $16.2M to $54.9M.